| AC-DILI | Amoxicillin-Clavulanate-Drug-Induced Liver Injury |
| AED | Aromatic Antiepileptic Drug |
| AIH | Autoimmune Hepatitis |
| ALT | Alanine Aminotransferase |
| ANA | Antinuclear Autoantibodies |
| ATLI | Antituberculosis Liver Injury |
| AZ-DILI | Azithromycin-Induced Drug-Induced Liver Injury |
| CI | Confidence Interval |
| DI-AIH | Drug-Induced Autoimmune Hepatitis |
| DI-AILD | Drug-Induced Autoimmune-Like Liver Disease |
| DILIN | Drug-Induced Liver Injury Network |
| DNA | Deoxyribonucleic Acid |
| DRESS | Drug Reaction with Eosinophilia and Systemic Symptoms |
| FasL | Fas Ligand |
| GWAS | Genome-Wide Association Studies |
| HDS | Herbal and Dietary Supplements |
| HLA | Human Leukocyte Antigen |
| IFN-γ | Interferon-γ |
| IM-DILI | Immune-Mediated Drug-Induced Liver Injury |
| MHC | Major Histocompatibility Complex |
| NGS | Next Generation Sequencing |
| NPV | Negative Predictive Value |
| NSAID | Non-Steroidal Anti-Inflammatory Drug |
| OR | Odds Ratio |
| PPV | Positive Predictive Value |
| RNA | Ribonucleic Acid |
| TB | Tuberculosis |
| Th | T helper |
| TMP–SMX | Trimethoprim-sulfamethoxazole |
| TNF-α | Tumor Necrosis Factor-alpha |
| ULN | Upper Limit of Normal |
| US | United States |